Search research articles
Contact Us
Filters
Showing results (101-110 of 313) with videos related to
Page
of 32
Sort By:
Therapeutics and Clinical Risk Management
|
December 31, 2020
Early Continence and Extravasation After Open Retropubic Radical Prostatectomy - Interrupted vs Continuous Suturing for Vesicourethral Anastomosis
Nora Köhler, Nasrin El-Bandar, Andreas Maxeiner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 21, 2009
Internal validation of an artificial neural network for prostate biopsy outcome
Carsten Stephan, Henning Cammann, Martin Bender, et al.
Cancer Letters
|
May 28, 2008
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma
Azizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
BMC Cancer
|
July 23, 2009
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
Angelika Tölle, Monika Jung, Michael Lein, et al.
BJU International
|
September 6, 2007
Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment
Heinrich Schulte-Baukloh, Tomas H Zurawski, Helmut H Knispel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 26, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study
Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
International Journal of Cancer
|
May 19, 2005
Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer
Steffen Weikert, Hans Krause, Ingmar Wolff, et al.
European Urology
|
August 30, 2005
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction
Heinrich Schulte-Baukloh, Catarina Weiss, Thomas Stolze, et al.
Anticancer Research
|
June 9, 2016
Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment
Christian F Jehn, Ingo J Diel, Friedrich Overkamp, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 3, 2008
Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure
Heinrich Schulte-Baukloh, Hans Bigalke, Kurt Miller, et al.
Page
of 32
Search research articles
Search
Showing results (101-110 of 313) with videos related to
Sort By:
Page
of 32
Therapeutics and Clinical Risk Management
|
December 31, 2020
Early Continence and Extravasation After Open Retropubic Radical Prostatectomy - Interrupted vs Continuous Suturing for Vesicourethral Anastomosis
Nora Köhler, Nasrin El-Bandar, Andreas Maxeiner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 21, 2009
Internal validation of an artificial neural network for prostate biopsy outcome
Carsten Stephan, Henning Cammann, Martin Bender, et al.
Cancer Letters
|
May 28, 2008
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma
Azizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
BMC Cancer
|
July 23, 2009
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
Angelika Tölle, Monika Jung, Michael Lein, et al.
BJU International
|
September 6, 2007
Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment
Heinrich Schulte-Baukloh, Tomas H Zurawski, Helmut H Knispel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 26, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study
Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
International Journal of Cancer
|
May 19, 2005
Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer
Steffen Weikert, Hans Krause, Ingmar Wolff, et al.
European Urology
|
August 30, 2005
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction
Heinrich Schulte-Baukloh, Catarina Weiss, Thomas Stolze, et al.
Anticancer Research
|
June 9, 2016
Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment
Christian F Jehn, Ingo J Diel, Friedrich Overkamp, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 3, 2008
Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure
Heinrich Schulte-Baukloh, Hans Bigalke, Kurt Miller, et al.
Page
of 32